Company Overview of Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc., a biopharmaceutical company, is engaged in the development and commercialization of microRNA (miRNA) therapeutics. The company focuses on miRNA-directed oncology therapies. It offers MRX34, a series of clinical therapeutic candidates to mimic the activity of a human miRNA. Its product candidates target cancers, such as solid and blood-borne tumors with a focus on hepatocellular carcinoma, non-small cell lung cancer, colorectal cancer, and pancreatic carcinoma. The company was founded in 2007 and is based in Austin, Texas. Mirna Therapeutics, Inc. operates as a subsidiary of Asuragen, Inc.
2150 Woodward Street
Austin, TX 78744
Founded in 2007
Key Executives for Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Hanson Technologies, Inc.||United States|
|MatTek Corporation||United States|
|Antrim Corporation||United States|
|Audeo Oncology, Inc.||United States|
|Matrix Genetics||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Mirna Therapeutics, Inc., please visit www.mirnatherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.